谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Subcutaneous (SC) Administration of Mosunetuzumab with Cycle 1 Step- up Dosing Is Tolerable and Active in Patients with Relapsed/Refractory B-Cell NonHodgkin Lymphomas (R/R B-NHL): Initial Results from a Phase I/II Study

Nancy L. Bartlett,Pratyush Giri,L. Elizabeth Budde,Stephen J. Schuster,Sarit Assouline,Matthew J. Matasar,Sung-Soo Yoon,Miguel Canales, Norma C. Gutierrez,Keith Fay,Chan-Yoon Cheah,Paula Marlton,Volker Wiebking,Shen Yin,Iris To,Chi-Chung Li,Huang Huang,Mingzhu Zhou,Elicia Penuel,Carol O'Hear,Laurie H. Sehn

Blood（2021）

引用 6|浏览46
暂无评分
关键词
mosunetuzumab,b-cell,non-hodgkin,b-nhl
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要